Can hydroxyzine cause a false‑positive urine immunoassay result for amphetamines?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Hydroxyzine Cause False-Positive Amphetamine Urine Drug Screens?

Yes, hydroxyzine can cause false-positive urine immunoassay results for amphetamines, though the evidence is limited to case reports and cross-reactivity studies rather than large-scale systematic investigations.

The Evidence

The available literature confirms hydroxyzine as a documented cause of false-positive amphetamine screens 1. While the FDA drug label for hydroxyzine does not specifically mention this cross-reactivity 2, research studies examining false-positive drug screens have identified hydroxyzine among antihistamines that can trigger spurious amphetamine results 3, 1.

Understanding the Mechanism

Immunoassay screening tests are inherently susceptible to cross-reactivity because they detect structural similarities rather than specific compounds 4. The screening immunoassays (enzyme-linked immunoassay or radioimmunoassay) are designed to be sensitive but sacrifice specificity, making them prone to false-positives when medications share molecular features with amphetamines 4, 5.

Clinical Approach When This Occurs

Immediate Steps:

  • Do not assume illicit drug use - obtain a complete medication history including all prescription and over-the-counter medications 4
  • Order confirmatory testing immediately using gas chromatography-mass spectrometry (GC-MS) or LC-MS/MS 4, 5
  • Document the patient's hydroxyzine use (dose, timing, indication)

Key Principle:

Confirmatory tests using mass spectrometry are highly unlikely to yield false-positive results and will definitively distinguish hydroxyzine from actual amphetamines 4. The confirmatory test will be negative for amphetamines if hydroxyzine was the cause of the initial positive screen.

Critical Caveats

The Two-Test System:

  • Screening immunoassays = presumptive only - never diagnostic alone 5, 6
  • Confirmatory testing = definitive - required before any clinical, legal, or employment decisions 4

Common Pitfall:

Acting on screening results alone can lead to:

  • Misdiagnosis of substance abuse
  • Inappropriate treatment decisions
  • Damaged physician-patient relationships
  • Legal/employment consequences 7

Other Medications to Consider:

If the confirmatory test is also positive, review for legitimate amphetamine prescriptions (e.g., amphetamine/dextroamphetamine for ADHD), which will appropriately test positive but represent therapeutic use, not abuse 4.

Practical Considerations

The frequency of this false-positive is not well-established - most evidence comes from case reports rather than large cohort studies 1. However, false-positive amphetamine screens overall account for 3.9-9.9% of positive amphetamine immunoassays in clinical laboratories 6, with multiple medications implicated including various antihistamines 3, 5.

Documentation Requirements:

When hydroxyzine causes a false-positive screen:

  • Document the medication list clearly in the medical record
  • Note that confirmatory testing was negative (once completed)
  • Explain the cross-reactivity to the patient
  • Provide written documentation if needed for employment/legal purposes

Always interpret drug screening results within the complete clinical context, including prescribed medications, patient history, and physical examination findings 4. Never rely on immunoassay screening alone for consequential decisions.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.